Skip to content

Tibotec licenses darunavir to Aspen in Africa

d4T dose can be reduced without loss of effectiveness, meta-analysis reports

Primary HIV infection responsible for half of all HIV transmission in Quebec

Patient retention challenges and the need for more active follow-up

CROI: high burden of side-effects from d4T leads to WHO dose reduction recommendation

South Africa: Activists welcome ambitious new AIDS plan

Next generation NRTI, apricitabine (ATC), shows early promise

CROI: ART: Helpful or harmful to kidney function?

Abbott to withhold new drugs from Thailand in retaliation for Kaletra compulsory license